玩弄秘书的奶又大又软,99香蕉国产精品偷在线观看,日本japanese熟睡人妻,99香蕉国产精品偷在线观看

咨詢熱線

15000266580

當(dāng)前位置:首頁  >  技術(shù)文章  >  日本批準(zhǔn)利用干細(xì)胞療法治療眼部疾病

日本批準(zhǔn)利用干細(xì)胞療法治療眼部疾病

更新時間:2013-07-26      點擊次數(shù):3200

   日本研究人員獲得批準(zhǔn),可以開展利用干細(xì)胞療法治療老年性黃斑變性(age-related macular degeneration,AMD),一種引起老年人視力下降的主要疾病。日本的研究人員誘導(dǎo)AMD患者身上取下的皮膚細(xì)胞使其處于一種類似于干細(xì)胞的狀態(tài)后再將其轉(zhuǎn)至患者,以達(dá)到治療效果。

干細(xì)胞具有廣泛的性,具有廣泛的醫(yī)療前景。去年,Kyoto University的Shinya Yamanaka即憑借干細(xì)胞領(lǐng)域的研究獲得諾貝爾獎。

詳細(xì)英文報道:

Japanese researchers have won permission to embark on a pioneering clinical study of a stem cell therapy for age-related macular degeneration, a major cause of vision loss in aging patients. The planned trial is being hailed as the first human test of a stem cell therapy made from patients' own cells.

Japan provides an appropriate proving ground for induced pluripotent stem (iPS) cell therapies. Last year professor Shinya Yamanaka of Kyoto University won a piece of a Nobel Prize for his work on converting adult cells into stem cells. The stem cells have broad potential in medicine because they can evolve into a variety to cell types with the potential to repair diseased or damaged organs, and they skirt the political quagmire of harvesting stem cells from human embryos.

As AFP reported, researchers in the Japanese study plan to take skin cells from AMD patients, coax the cells into a stem-like state, and then reintroduce them to the patients. The study calls for testing the therapeutic approach in 6 patients, with the trial set to begin next year in Kobe. Applications to conduct the trial came from the Riken Center for Developmental Biology and the Institute of Biomedical Research and Innovation.

Stem cells offer a whole new way to treat vision problems. Today, AMD patients take injected therapies such as Eylea and Lucentis to combat the disease by inhibiting VEGF to stymie the formation of leaky blood vessels, which lead to deterioration of the eye tissue that is key to central vision.

However, with pioneering clinical trials comes great risk. As professor Chris Mason of University College London noted to the BBC, researchers lack evidence on the safety of iPS cells in humans. The hope is that using patients' own cells to generate the therapies could reduce the risk of their bodies rejecting the stem cells.

 

聯(lián)系方式

郵箱:xiangfbio@163.com

地址:上海市虹口區(qū)四平路710號7層

咨詢熱線

400-821-8510

(周一至周日9:00- 19:00)

在線咨詢
  • 掃一掃 微信咨詢

Copyright©2025 上海復(fù)祥生物科技有限公司 All Right Reserved    備案號:滬ICP備10013034號-2     sitemap.xml
技術(shù)支持:化工儀器網(wǎng)    管理登陸
日本不卡三区| 囯产精品久久久久久久久免费蜜桃| 久久婷婷五月综合97色一本一本| 国产又猛又黄又爽| 亚洲日本va中文字幕| 诱人的大乳BD在线观看| 亚洲AV色香蕉一区二区三区| 国产96在线 | 欧美| 国产亚洲精品aaaa片小说| 亚洲伦产精品一区二区三区| 亚洲一区二区观看播放| 日本不卡三区| 色94色欧美sute亚洲线路二| 国产精品黄在线观看免费软件| 欧美大肥婆大肥bbbbb| 99国产精品无码| 最近中文字幕大全| 日本人妻伦在线中文字幕| 国偷自产AV一区二区三区123| 一本大道无码人妻精品专区| 亚洲精品无码永久在线观看你懂的| 国产乱妇无乱码大黄aa片| 国产成人精品无码免费播放| 最近2019中文字幕电影免费看| 狠狠挺进稚嫩学生小身体| 日韩亚洲AV人人夜夜澡人人爽 | 久久久精品人妻一区二区三区四区| 日韩精品无码人妻一区二区三区| 国产+高潮+白浆| 国产欧美日韩精品丝袜高跟鞋| 三上悠亚人妻中文字幕在线| 国产麻豆精东果冻乌鸦传媒| 日本yokogawa| 精品人妻人人做人人爽| 熟妇人妻AV无码一区二区三区| 亚洲AV无码一区二区三区在线观看| 免费看裸裸体美女啪啪无遮挡| 少妇高h肉辣全集目录| 久久碰国产一区二区三区| 99久久综合狠狠综合久久| 国产国产国产国产系列|